PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsprecursor b-cell lymphoblastic leukemia-lymphoma
MeSH D015452 - precursor b-cell lymphoblastic leukemia-lymphoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D054198:Precursor cell lymphoblastic leukemia-lymphoma
$
Success rate
D015452: 
Precursor b-cell lymphoblastic leukemia-lymphoma
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
71%
10/14
Phase 2
0%
0/11
Phase 3
0%
0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use